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Objectives
Sepsis is characterized by capillary leakage followed by
organ dysfunction. Sphingosine-1-phosphate (S1P) is a
signalling lipid that regulates endothelial permeability.
Here we investigated whether serum S1P concentrations
are associated with sepsis severity.
Methods
Primary outcome variable was the serum S1P concentra-
tion quantified by mass spectrometry. Blood was drawn at
day of enrollment. S1P was correlated with inflammatory
markers and Sequential Organ Failure Assessment Score
(SOFA) score for sepsis severity.
Results
All three groups of patients had significantly (P < 0.001)
lower serum S1P concentrations than controls (median
457.9 µg/L; interquartile range, IQR 379.8-562.3 µg/L).
The lowest S1P concentrations was found in the septic
shock group (149.1 µg/L; IQR, 105.1-163.2 µg/L) com-
pared to patients with severe sepsis (234.7 µg/L; IQR,
185.4-342.6 µg/L) and sepsis (246.7 µg/L; IQR, 201.7-
306.0 µg/L). S1P levels were positively correlated with
high-density lipoprotein (HDL), and red blood cell count
(RBC) and negatively correlated with: procalcitonin, inter-
leukin-6, C-reactive protein and lactate. In a multivariate
linear regression model S1P, HDL and RBC were signifi-
cantly associated with SOFA score (P < 0.001). S1P con-
centration below 158.2 µg/l was the most potent indicator
for diagnosing sepsis with shock compared to all other
inflammatory markers. In a multivariate logistic regression
model calculated for prediction of septic shock the Odds
ratio for S1P was 0.97 (CI 95% 0.96-0.99) and the best pre-
dictor of shock (P < 0.01) among all parameters tested.
Conclusions
S1P is an indicator of sepsis severity and superior to predict
septic shock than currently established markers. Further
prospective studies are needed to confirm the results in a
larger cohort of non-septic patients and controls.
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